CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+6.63%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.21B
AUM Growth
+$7.21B
(+11%)
Cap. Flow
+$312M
Cap. Flow
% of AUM
4.33%
Top 10 Holdings %
Top 10 Hldgs %
73.33%
Holding
137
New
11
Increased
45
Reduced
45
Closed
6
Top Buys
| 1 |
Coca-Cola
KO
|
$300M |
| 2 |
Procter & Gamble
PG
|
$113M |
| 3 |
HDFC Bank
HDB
|
$15.9M |
| 4 |
Merck
MRK
|
$7.84M |
| 5 |
Alkermes
ALKS
|
$6.65M |
Top Sells
| 1 |
TSMC
TSM
|
$71.3M |
| 2 |
Visa
V
|
$18.7M |
| 3 |
Home Depot
HD
|
$9.69M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$9.36M |
| 5 |
Glaukos
GKOS
|
$8.09M |
Sector Composition
| 1 | Financials | 29.05% |
| 2 | Consumer Discretionary | 18.26% |
| 3 | Communication Services | 15.15% |
| 4 | Healthcare | 13.9% |
| 5 | Consumer Staples | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
51
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.88M | 0.1% | 415,485 +134,185 | +48% | +$2.22M |
|
52
Exact Sciences
EXAS
$8.98B
| $6.74M | 0.09% | 112,699 +24,006 | +27% | +$1.44M |
|
53
NovoCure
NVCR
$1.38B
| $6.67M | 0.09% | 213,153 +44,832 | +27% | +$1.4M |
|
54
Bristol-Myers Squibb
BMY
$96B
| $6.65M | 0.09% | 120,199 -63,208 | -34% | -$3.5M |
|
|
55
Alkermes
ALKS
$4.78B
| $6.65M | 0.09% | +161,466 | New | +$6.65M |
|
|
AIMT
56
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $6.64M | 0.09% | 246,749 +123,466 | +100% | +$3.32M |
|
|
XENT
57
DELISTED
Intersect ENT, Inc
XENT
| $6.35M | 0.09% | 169,435 +58,402 | +53% | +$2.19M |
|
58
Cigna
CI
$80.3B
| $6.24M | 0.09% | 36,723 | – | – |
|
|
59
TSMC
TSM
$1.2T
| $6.16M | 0.09% | 168,390 -1,950,333 | -92% | -$71.3M |
|
|
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.57M | 0.08% | 147,587 +54,988 | +59% | +$2.08M |
|
|
TVRD
61
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $5.55M | 0.08% | 289,950 +58,175 | +25% | +$1.11M |
|
|
PRTK
62
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $5.47M | 0.08% | 536,128 +37,875 | +8% | +$386K |
|
|
KTWO
63
DELISTED
K2M Group Holdings, Inc
KTWO
| $5.35M | 0.07% | 237,603 +50,721 | +27% | +$1.14M |
|
64
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.32M | 0.07% | 56,512 | – | – |
|
|
LHCG
65
DELISTED
LHC Group LLC
LHCG
| $5.02M | 0.07% | +58,667 | New | +$5.02M |
|
66
Iovance Biotherapeutics
IOVA
$807M
| $4.93M | 0.07% | +385,446 | New | +$4.93M |
|
67
Aclaris Therapeutics
ACRS
$209M
| $4.84M | 0.07% | 242,251 +166,986 | +222% | +$3.33M |
|
|
CLVS
68
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.84M | 0.07% | 106,405 -29,943 | -22% | -$1.36M |
|
69
Zimmer Biomet
ZBH
$21B
| $4.55M | 0.06% | 40,830 -18,809 | -32% | -$2.1M |
|
|
GWPH
70
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.45M | 0.06% | 31,858 +6,148 | +24% | +$858K |
|
|
DERM
71
DELISTED
Dermira, Inc.
DERM
| $4.43M | 0.06% | 481,670 +360,767 | +298% | +$3.32M |
|
|
ONCE
72
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $4.27M | 0.06% | 51,596 +9,822 | +24% | +$813K |
|
|
AXDX
73
DELISTED
Accelerate Diagnostics
AXDX
| $4.11M | 0.06% | +184,310 | New | +$4.11M |
|
74
Ultragenyx Pharmaceutical
RARE
$2.89B
| $4.06M | 0.06% | 52,834 -9,143 | -15% | -$703K |
|
|
NUVA
75
DELISTED
NuVasive, Inc.
NUVA
| $3.98M | 0.06% | 76,399 -5,452 | -7% | -$284K |
|